Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment

American Journal of Psychiatry

Volumn 158, Issue 9, 2001, Pages 1517-1519

  Nagaraja, D ^a   Jayashree, S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PIRIBEDIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; COGNITION DISORDERS; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRIBEDIL; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034856154     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.9.1517     Document Type: Article

References (4)

1. Mild cognitive impairment: Conceptual basis and current nosological status
2. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals
3. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism
4. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician